Business
AtaiBeckley Joins $3 Trillion CRSP Index and S&P Benchmark Indices Adding Mandatory Passive Fund Ownership to Phase 3 Pipeline Catalyst
Inclusion in U.S. CRSP® benchmark indices triggers mandatory position-building by passive index funds tracking more than $3 trillion in AUM, including the world’s largest mutual fundExpands market presence across the S&P Total Market Index, covering virtually all U.S.-listed equities, and the S&P Completion Index, which represents approximately 3,000 mid-, small-, and micro-cap companies not included in the S&P 500®Continues a series of index inclusions across the U.S. equity benchmark landscape
About this update from Ataibeckley Inc.
[{"type":"image","alt":"AtaiBeckley Inc.","displaySize":"","headline":null,"caption":"AtaiBeckley Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":58,"url":"https://media.zenfs.com/en/globenewswire.com/e9407e6d9b05eb9b99554770392e8e10"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/DvkZWt4iwQZrF036qM8M7Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTgx/https://media.zenfs.com/en/globenewswire.com/e9407e6d9b05eb9b99554770392e8e10","width":300,"height":58}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Inclusion in U.S. CRSP® benchmark indices triggers mandatory position-building by passive index funds tracking more than $3 trillion in AUM, including the world’s largest mutual fund","length":182,"tagName":"p"}]},{"val":[{"type":"text","content":"Expands market presence across the S&P Total Market Index, covering virtually all U.S.-listed equities, and the S&P Completion Index, which represents approximately 3,000 mid-, small-, and micro-cap companies not included in the S&P 500®","length":249,"tagName":"p"}]},{"val":[{"type":"text","content":"Continues a series of index inclusions across the U.S. equity benchmark landscape, reflecting AtaiBeckley’s enhanced eligibility following its U.S. re-domiciliation and building on its addition to the Nasdaq Biotechnology Index in December 2025","length":244,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":675,"olType":false},{"type":"text","content":"NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments, today announced its addition to the S&P Total Market Index, the S&P Completion Index and CRSP® U.S. benchmark indices, effective March 23, 2026. BPL-003 Phase 3 program remains on track to initiate in Q2 2026, and topline data from the VLS-01 Phase 2b study are expected in H2 2026.","length":556,"tagName":"p"},{"type":"text","content":"Srinivas Rao, Co-Founder and Chief Executive Officer of AtaiBeckley, said: "Being added to the S&P Total Market Index, S&P Completion Index, and CRSP U.S. benchmark indices reflects meaningful recognition of AtaiBeckley's enhanced presence in U.S. equity markets, with ...